Senior insider sale
Chief Financial Officer at ENFUSION, INC. — senior position signals high conviction
$371.7K
34.76K shares
What this filing means
HERRING BRADLEY plans to sell 34.76K shares of ENFUSION, INC. valued at approximately $371.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2025ACC: 0001959173-25-001726
Officer· Chief Financial Officer
Since Dec 2022
34.76K
Shares to sell
$371.7K
Approx. market value
4.64K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/4/2025
4.64KTotal acquired4.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2025 | Restricted Stock Vesting Compensation | 4.64K | — |
| Total | 4.64K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.53K
Market value
$17.6K
3/3/2025
—Completed
Units to sell
4.13K
Market value
$41.9K
1/7/2025
—Completed
Units to sell
24.44K
Market value
$259.4K
12/20/2024
Planned — Approximate Date
NYSEPlanned
Units to sell
4.64K
Market value
$52.8K
3/5/2025
Total
Units
34.76K
Value
$371.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2025 | 1.53K | $17.6K | — | Completed |
1/7/2025 | 4.13K | $41.9K | — | Completed |
12/20/2024 | 24.44K | $259.4K | — | Completed |
| Planned — Approximate Date | ||||
3/5/2025 | 4.64K | $52.8K | NYSE | Planned |
| Total | 34.76K | $371.7K | ||